INTERNATIONAL PATENT: JANSSEN BIOTECH, INC. FILES APPLICATION FOR "BISPECIFIC ANTIBODY TARGETING HK2 AND CD3 FOR THE TREATMENT OF PROSTATE CANCER"

GENEVA, Feb. 24 -- JANSSEN BIOTECH, INC. (800/850 Ridgeview DriveHorsham, PA 19044) filed a patent application (PCT/US2025/041637) for "BISPECIFIC ANTIBODY TARGETING HK2 AND CD3 FOR THE TREATMENT OF PROSTATE CANCER" on Aug 12, 2025. With publication no. WO/2026/039420, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Sherry, Chia-E (c/o Janssen Research & Development, LLC920 US Route 202, P.O. Box 300Raritan, NJ 08869), VILLALOBOS, Victor, Manuel (c/o Janssen Research & Development, LLC920 US Route 202, P.O. Box 300R...